HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Valeria Bruno Selected Research

xanthurenic acid

2/2024Changes in kynurenine metabolites in the gray and white matter of the dorsolateral prefrontal cortex of individuals affected by schizophrenia.
1/2017Cinnabarinic acid and xanthurenic acid: Two kynurenine metabolites that interact with metabotropic glutamate receptors.
12/2015Xanthurenic Acid Activates mGlu2/3 Metabotropic Glutamate Receptors and is a Potential Trait Marker for Schizophrenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Valeria Bruno Research Topics

Disease

9Schizophrenia (Dementia Praecox)
02/2024 - 08/2007
8Alzheimer Disease (Alzheimer's Disease)
01/2020 - 08/2002
6Ischemia
01/2020 - 12/2008
5Neuroinflammatory Diseases
02/2024 - 07/2002
4Multiple Sclerosis
07/2020 - 07/2002
3Pain (Aches)
01/2022 - 10/2012
3Absence Epilepsy (Childhood Absence Epilepsy)
11/2020 - 02/2015
3Epilepsy (Aura)
01/2019 - 12/2008
3Parkinson Disease (Parkinson's Disease)
01/2017 - 08/2009
3Mental Disorders (Mental Disorder)
01/2017 - 12/2015
3Brain Ischemia (Cerebral Ischemia)
12/2008 - 03/2005
3Glioma (Gliomas)
08/2007 - 03/2003
2Autistic Disorder (Autism)
11/2023 - 03/2014
2Spinocerebellar Ataxias (Spinocerebellar Ataxia)
12/2022 - 02/2015
2Chronic Pain
01/2022 - 01/2017
2Infarction (Infarctions)
01/2021 - 02/2009
2Autoimmune Diseases (Autoimmune Disease)
07/2020 - 01/2011
2Psychotic Disorders (Schizoaffective Disorder)
01/2019 - 03/2011
2Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2018 - 02/2015
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2017 - 04/2011
2Neuralgia (Stump Neuralgia)
01/2017 - 10/2012
2Neoplasms (Cancer)
01/2011 - 07/2005
2Parkinsonian Disorders (Parkinsonism)
08/2009 - 01/2004
2Temporal Lobe Epilepsy
12/2008 - 04/2007
2Neurodegenerative Diseases (Neurodegenerative Disease)
03/2008 - 05/2007
2Seizures (Absence Seizure)
04/2007 - 08/2005
2Hypoxia (Hypoxemia)
03/2007 - 08/2004
1Stroke (Strokes)
01/2023
1Cerebellar Diseases (Cerebellar Syndrome)
12/2022
1Anhedonia
11/2021
1Diabetic Neuropathies (Diabetic Neuropathy)
01/2020
1Retinal Degeneration
11/2017
1Generalized Epilepsy
11/2017
1Inflammation (Inflammations)
01/2017
1Disease Progression
01/2017
1Major Depressive Disorder (Major Depressive Disorders)
01/2017
1Catalepsy
08/2015
1Adjustment Disorders (Adjustment Disorder)
06/2015
1AIDS-Related Complex (ARC)
03/2014

Drug/Important Bio-Agent (IBA)

15Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
11/2023 - 03/2003
11Glutamic Acid (Glutamate)FDA Link
01/2019 - 07/2005
6LigandsIBA
01/2019 - 08/2007
5KynurenineIBA
02/2024 - 12/2015
4Proteins (Proteins, Gene)FDA Link
12/2022 - 03/2005
4LY 341495IBA
10/2012 - 03/2003
4Amyloid beta-PeptidesIBA
03/2011 - 08/2002
3xanthurenic acidIBA
02/2024 - 12/2015
3Tryptophan (L-Tryptophan)FDA Link
02/2024 - 12/2015
3Freund's AdjuvantIBA
01/2022 - 10/2012
3Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
01/2021 - 08/2009
3Antipsychotic Agents (Antipsychotics)IBA
12/2020 - 12/2015
3Endothelin-1 (Endothelin 1)IBA
01/2017 - 02/2009
2cupric sulfide (CuS)IBA
11/2021 - 06/2015
2cinnabarinic acidIBA
12/2020 - 01/2017
2Analgesics (Analgesic Drugs)IBA
01/2017 - 10/2012
2Fingolimod Hydrochloride (FTY720)FDA Link
06/2015 - 01/2013
2Brain-Derived Neurotrophic Factor (BDNF)IBA
06/2015 - 04/2009
21- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
09/2012 - 01/2004
2Kainic Acid (Kainate)IBA
12/2008 - 04/2007
1AcidsIBA
02/2024
1Quinolinic AcidIBA
02/2024
13-hydroxykynurenineIBA
02/2024
1Kynurenic Acid (Kynurenate)IBA
02/2024
1Phosphatidylinositol PhosphatesIBA
11/2023
1AminesIBA
10/2023
1Antihypertensive Agents (Antihypertensives)IBA
01/2023
1Ataxin-1IBA
12/2022
1CannabinoidsIBA
12/2022
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
12/2022
1Chondroitin ABC LyaseIBA
01/2022
1CorticosteroneIBA
11/2021
1Sucrose (Saccharose)IBA
11/2021
1Phosphates (Orthophosphate)IBA
01/2021
1Mannose (D-Mannose)IBA
01/2021
1Interleukin-4 Receptors (Interleukin 4 Receptor)IBA
01/2021
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1N- cyclobutyl- 6- ((3- fluorophenyl)ethynyl)nicotinamideIBA
11/2020
1EnzymesIBA
07/2020
1Hydrogen Sulfide (Sulfide, Hydrogen)IBA
07/2020
1GYY 4137IBA
07/2020
1Macrophage Migration-Inhibitory FactorsIBA
01/2020
1CB1 Cannabinoid Receptor (CB1 Receptor)IBA
01/2020
1Acetylcysteine (Siran)FDA LinkGeneric
01/2020
1Glutamate Receptors (Glutamate Receptor)IBA
01/2019
1Sodium Glutamate (Accent)IBA
11/2017
1ThrombospondinsIBA
11/2017
1Immunoglobulin E (IgE)IBA
11/2017
1Biomarkers (Surrogate Marker)IBA
01/2017
1Endothelium-Dependent Relaxing Factors (Endothelium Derived Relaxing Factor)IBA
01/2017
1Acetylcarnitine (Alcar)IBA
01/2017
1Messenger RNA (mRNA)IBA
10/2015
1Haloperidol (Haldol)FDA LinkGeneric
08/2015
1Antidepressive Agents (Antidepressants)IBA
06/2015
1Histone Deacetylases (Histone Deacetylase)IBA
06/2015
1Ligases (Synthetase)IBA
03/2014
1Homer Scaffolding Proteins (Homer 1)IBA
03/2014

Therapy/Procedure

4Analgesia
01/2022 - 10/2012
2Therapeutics
01/2011 - 08/2009
1Controlled Hypotension
01/2017